|
WO2008134729A1
|
|
Diagnosis and treatment of type 1 diabetes
|
|
WO2007081804A2
|
|
Regulators of nfat
|
|
WO2006119083A2
|
|
Treating gastrointestinal diseases with modulation of retonic acid
|
|
WO2006116185A2
|
|
Methods for the treatment of multiple myeloma
|
|
WO2006004752A1
|
|
Gelling electrophoresis loading buffer
|
|
US2005276811A1
|
|
Natural IgM antibodies and inhibitors thereof
|
|
WO2005079515A2
|
|
Conformation specific antibodies
|
|
US2005191299A1
|
|
CD70 inhibition for the treatment and prevention of inflammatory bowel disease
|
|
US2008153764A1
|
|
System and Methods For Short Rna Expression
|
|
WO2004110356A2
|
|
Methods for modulating cell-to-cell adhesion using an agonist of c1inh-type protein activity
|
|
WO2005044840A2
|
|
Modulation of anergy and methods for isolating anergy-modulating compounds
|
|
WO2004069200A2
|
|
Specific inhibitors of nfat activation by calcineurin and their use in treating immune-related diseases
|
|
US6929792B1
|
|
Modified dendritic cells and use therefor
|
